Protocol Ledger

NCT06773962 · Phase II · ACTIVE NOT RECRUITING

A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease

Interventional Phase II clinical trial protocol NCT06773962 sponsored by TrueBinding in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-03-20 Enrollment: 62 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06773962
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)62 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06773962
Protocol FieldVerified Registry Value
NCT IdentifierNCT06773962
Consolidated Lead SponsorTrueBinding
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment62 participants (ESTIMATED)
Registered Start Date2025-03-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06773962
Hospital Research SiteLocationSite Profile
University of MiamiMiami, FLOpen Hospital Dossier ->
University of Kansas Medical CenterKansas City, KSOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI